UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

The Dynamics of Signaling as a Pharmacological Target

Cell, 2013-10, Vol.155 (2), p.448-461

2013

Volltextzugriff (PDF)

Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity

Science (American Association for the Advancement of Science), 2005-09, Vol.309 (5742), p.1857-1861

2005

Volltextzugriff (PDF)

Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis

PloS one, 2016-11, Vol.11 (11), p.e0165089-e0165089

2016

Volltextzugriff (PDF)

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients

British journal of cancer, 2015-10, Vol.113 (8), p.1225-1233

2015

Volltextzugriff (PDF)

Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic

Molecular cancer therapeutics, 2015-07, Vol.14 (7), p.1625-1636

2015

Volltextzugriff (PDF)

IκBε Provides Negative Feedback to Control NF-κB Oscillations, Signaling Dynamics, and Inflammatory Gene Expression

The Journal of cell biology, 2006-06, Vol.173 (5), p.659-664

2006

Volltextzugriff (PDF)

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

Journal of circulating biomarkers, 2015-01, Vol.4, p.3-3

2015

Volltextzugriff (PDF)

A homeostatic model of IκB metabolism to control constitutive NF-κB activity

Molecular systems biology, 2007-05, Vol.3 (1), p.n/a

2007

Volltextzugriff (PDF)

Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses

The Journal of biological chemistry, 2006-02, Vol.281 (5), p.2945-2950

2006

Volltextzugriff (PDF)

Use of an Innovative Pharmaceutical Class Scoring Tool for Prioritized Annual Formulary Review

Innovations in pharmacy, 2022, Vol.13 (2), p.7

2022

Volltextzugriff (PDF)

The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome

Genes & development, 2010-07, Vol.24 (13), p.1434-1447

2010

Volltextzugriff (PDF)

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

Journal of circulating biomarkers, 2015-05, Vol.4 (1), p.3

2015

Volltextzugriff (PDF)

Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliability

Journal of managed care & specialty pharmacy, 2021-04, Vol.27 (4), p.488

2021

Volltextzugriff (PDF)

Collateral effects of behavioral parent training on families of children with developmental disabilities and behavior disorders

Behavioral interventions, 2002-04, Vol.17 (2), p.75-83

2002

Volltextzugriff (PDF)

Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20

Genes & development, 2008-08, Vol.22 (15), p.2093-2101

2008

Volltextzugriff (PDF)

A Fourth IκB Protein within the NF-κB Signaling Module

Cell, 2007-01, Vol.128 (2), p.369-381

2007

Volltextzugriff (PDF)

Accelerated Dosing of Infliximab Is Not Associated With Improved Colectomy Rates in Hospitalized Severe Ulcerative Colitis Patients: 692

The American journal of gastroenterology, 2017-10, Vol.112, p.S382-S383

2017

Volltextzugriff (PDF)

Rapid and step-wise eye growth in molting diving beetle larvae

Journal of Comparative Physiology, 2015-11, Vol.201 (11), p.1091-1102

2015

Volltextzugriff (PDF)

Hepatitis C virus direct-acting antiviral nonadherence: Relationship to sustained virologic response and identification of at-risk patients

Journal of the American Pharmacists Association, 2019-01, Vol.59 (1), p.51-56

2019

Volltextzugriff (PDF)

Sa1906 - Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S389-S389

2017

Volltextzugriff (PDF)

Abstract 1584: Analytical and clinical validation of the Epic Circulating Tumor Cell (CTC) Platform: enrichment-free CTC detection and biomarker characterization

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1584-1584

2015

Volltextzugriff (PDF)

Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22034-e22034

2015

Volltextzugriff (PDF)

Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S389-S389

2017

Volltextzugriff (PDF)

Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.195-195

2016

Volltextzugriff (PDF)

Abstract A34: Single cell genomic profiling of circulating tumor cells (CTCs) in metastatic disease to characterize disease heterogeneity

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.A34-A34

2015

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Aktive Filter

KollektionERIC

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(154)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(178)
Japanisch
(13)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Dynamics of Signaling as a Pharmacological Target

Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity

Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients

Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic

IκBε Provides Negative Feedback to Control NF-κB Oscillations, Signaling Dynamics, and Inflammatory Gene Expression

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

A homeostatic model of IκB metabolism to control constitutive NF-κB activity

Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses

Use of an Innovative Pharmaceutical Class Scoring Tool for Prioritized Annual Formulary Review

The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliability

Collateral effects of behavioral parent training on families of children with developmental disabilities and behavior disorders

Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20

A Fourth IκB Protein within the NF-κB Signaling Module

Accelerated Dosing of Infliximab Is Not Associated With Improved Colectomy Rates in Hospitalized Severe Ulcerative Colitis Patients: 692

Rapid and step-wise eye growth in molting diving beetle larvae

Hepatitis C virus direct-acting antiviral nonadherence: Relationship to sustained virologic response and identification of at-risk patients

Sa1906 - Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab

Abstract 1584: Analytical and clinical validation of the Epic Circulating Tumor Cell (CTC) Platform: enrichment-free CTC detection and biomarker characterization

Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC)

Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab

Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC)

Abstract A34: Single cell genomic profiling of circulating tumor cells (CTCs) in metastatic disease to characterize disease heterogeneity

Aktive Filter

Suchergebnisse filtern